UK's Redx spins out cancer unit with 120 researchers
This article was originally published in Scrip
Executive Summary
A new cancer R&D firm based in Liverpool, UK, was launched today with public sector funding and a portfolio of drug candidates from its originator firm, Redx Pharma.